Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002885878 | SCV003243311 | benign | not provided | 2023-10-11 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003994469 | SCV004813125 | uncertain significance | not specified | 2024-02-26 | criteria provided, single submitter | clinical testing | Variant summary: POLA1 c.1555A>G (p.Met519Val) results in a conservative amino acid change located in the DNA-directed DNA polymerase, family B, exonuclease domain (IPR006133) of the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 7.7e-05 in 182840 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in POLA1 causing X-Linked Intellectual Disability, Van Esch Type, allowing no conclusion about variant significance. To our knowledge, no occurrence of c.1555A>G in individuals affected with X-Linked Intellectual Disability, Van Esch Type and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 2037584). Based on the evidence outlined above, the variant was classified as uncertain significance. |